Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.
- DOI
- 10.1158/1078-0432.ccr-24-3721
- Published
- 2025 Aug 14
- Container
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-24-3721,
title = {Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.},
author = {Yu B and Kline C and Hoare O and Jung J and Knowles T and Ranavaya A and Minturn J and Banerjee A and Leary S and Crotty E and Abdelbaki M and Whipple N and Goldman S and Margol A and Bhatia A and Dababo N and George E and Nabavizadeh A and Pampaloni MH and Inagaki A and Collins S and Chuntova P and Barcova M and Patel TS and Phillips J and Prados M and Molinaro A and Gupta N and Raffel C and Cole K and Kasahara N and Diaz AA and Mueller S},
year = {2025},
journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
doi = {10.1158/1078-0432.ccr-24-3721},
url = {https://doi.org/10.1158/1078-0432.ccr-24-3721}
}RIS
TY - JOUR TI - Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005. AU - Yu B AU - Kline C AU - Hoare O AU - Jung J AU - Knowles T AU - Ranavaya A AU - Minturn J AU - Banerjee A AU - Leary S AU - Crotty E AU - Abdelbaki M AU - Whipple N AU - Goldman S AU - Margol A AU - Bhatia A AU - Dababo N AU - George E AU - Nabavizadeh A AU - Pampaloni MH AU - Inagaki A AU - Collins S AU - Chuntova P AU - Barcova M AU - Patel TS AU - Phillips J AU - Prados M AU - Molinaro A AU - Gupta N AU - Raffel C AU - Cole K AU - Kasahara N AU - Diaz AA AU - Mueller S PY - 2025 JO - Clinical cancer research : an official journal of the American Association for Cancer Research DO - 10.1158/1078-0432.ccr-24-3721 UR - https://doi.org/10.1158/1078-0432.ccr-24-3721 ER -
APA
B, Y., C, K., O, H., J, J., T, K., A, R., J, M., A, B., S, L., E, C., M, A., N, W., S, G., A, M., A, B., N, D., E, G., A, N., MH, P., A, I., S, C., P, C., M, B., TS, P., J, P., M, P., A, M., N, G., C, R., K, C., N, K., AA, D., & S, M. (2025). Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-3721
Source records
- pubmed · retrieved 2026-11-11T01:50:00.739Z